Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy

Claudia Gonzaga‐Jauregui(Duke University), Tamar Harel(Baylor College of Medicine), Tomasz Gambin(Baylor College of Medicine), Maria Kousi(Duke University), Laurie B. Griffin(University of Michigan), Ludmila Francescatto(Duke University), Burçak Özeş(Boğaziçi University), Ender Karaca(Baylor College of Medicine), Shalini N. Jhangiani(Baylor College of Medicine), Matthew N. Bainbridge(Baylor College of Medicine), Kim Lawson(The University of Texas Health Science Center at Houston), Davut Pehli̇van(Baylor College of Medicine), Yuji Okamoto(Baylor College of Medicine), Marjorie Withers(Baylor College of Medicine), Pedro Mancías, Anne Slavotinek(University of California, San Francisco), Pamela J. Reitnauer(University of North Carolina at Chapel Hill), Meryem Tuba Goksungur(Istanbul University), Michael E. Shy(University of Iowa), Thomas O. Crawford(Johns Hopkins University), Michel Koenig(Centre National de la Recherche Scientifique), Jason R. Willer(Duke University), Brittany N. Flores(University of Michigan), Igor Pediaditrakis(Duke University), Önder Us(Acıbadem Adana Hospital), Wojciech Wiszniewski(Baylor College of Medicine), Yeşim Parman(Istanbul University), Anthony Antonellis(University of Michigan), Donna M. Muzny(Baylor College of Medicine), Nicholas Katsanis(Duke University), Esra Battaloglu(Boğaziçi University), Eric Boerwinkle(Baylor College of Medicine), Richard A. Gibbs(Baylor College of Medicine), James R. Lupski(Baylor College of Medicine)
Cell Reports
August 1, 2015
Cited by 246Open Access
Full Text

Abstract

Charcot-Marie-Tooth (CMT) disease is a clinically and genetically heterogeneous distal symmetric polyneuropathy. Whole-exome sequencing (WES) of 40 individuals from 37 unrelated families with CMT-like peripheral neuropathy refractory to molecular diagnosis identified apparent causal mutations in ∼ 45% (17/37) of families. Three candidate disease genes are proposed, supported by a combination of genetic and in vivo studies. Aggregate analysis of mutation data revealed a significantly increased number of rare variants across 58 neuropathy-associated genes in subjects versus controls, confirmed in a second ethnically discrete neuropathy cohort, suggesting that mutation burden potentially contributes to phenotypic variability. Neuropathy genes shown to have highly penetrant Mendelizing variants (HPMVs) and implicated by burden in families were shown to interact genetically in a zebrafish assay exacerbating the phenotype established by the suppression of single genes. Our findings suggest that the combinatorial effect of rare variants contributes to disease burden and variable expressivity.


Related Papers

No related papers found

Powered by citation graph analysis